用户名:  密码:   
网站首页即时通讯活动公告最新消息科技前沿学人动向两岸三地人在海外历届活动关于我们联系我们申请加入
栏目导航 — 美国华裔教授专家网科技动向学人动向
关键字  范围   
 
USC geneticist Marlena Fejzo named one of Time magazine’s 2024 ‘Women of the Year’
2024/3/19 10:35:35 | 浏览:1007 | 评论:0

USC geneticist Marlena Fejzo named one of Time magazine’s 2024 ‘Women of the Year’

Marlena Fejzo of the Keck School of Medicine of USC has been named one of Time magazine’s 2024 “Women of the Year.”(Photo/Christina Gandolfo)


The recognition follows the Keck School of Medicine professor’s recent study that showed that a hormone produced by the fetus triggers nausea and vomiting during pregnancy.

February 21, 2024
By Leigh Hopper
USC geneticist Marlena Fejzo, whose discovery of the cause of morning sickness in pregnancy brought international attention to her work, is one of Time magazine’s 2024 “Women of the Year,” the publication announced Wednesday.

The recognition follows Fejzo’s recent study in Nature that showed that a hormone produced by the fetus — and the mother’s sensitivity to it — triggers nausea and vomiting during pregnancy.

Up to 80% of pregnant women experience morning sickness, more accurately known as pregnancy sickness since it can occur at any time of day. Another 2% are affected by a severe form called hyperemesis gravidarum, or HG, which can cause dehydration, weight loss, electrolyte imbalances and hospitalization.

“Dr. Fejzo’s persistence in understanding HG, and her exceptional research, has advanced our understanding of the biology of HG, which is information that will be used to improve health outcomes for both mothers at risk and their children,” said Christopher Haiman, director of the Center for Genetic Epidemiology at the Keck School of Medicine of USC.

Fejzo’s life’s work
Fejzo, who joined Haiman’s Center for Genetic Epidemiology last year, endured HG herself. For months in 1999, pregnant with her second child, she suffered intense nausea, unable to keep anything down. As she literally starved and became too weak to stand, her doctor floated theories about the cause:It was psychological, a bid for sympathy from her husband or a way to get attention from her parents.

At 15 weeks, she lost the pregnancy.

Finding the cause of her condition became her life’s work.

Despite the severity of the condition — which includes the potential for maternal death — few scientists study it, and, historically, funding is difficult to find. The National Institutes of Health has funded only six hyperemesis studies since 2007. Fejzo, whose day job at UCLA at the time was studying ovarian cancer, chipped away at the HG puzzle during her evenings and weekends.

A major breakthrough
A breakthrough came when the 23andMe DNA testing company agreed, at Fejzo’s request, to include a few questions about hyperemesis in a survey. A few years later, she worked with the company to scan the genetic data of more than 50,000 research participants for genes associated with pregnancy sickness.

The results pointed to a specific gene, one that encodes a hormone called GDF15.

Subsequent work suggested two possible solutions for pregnancy sickness:a treatment that could lower levels of the hormone GDF15 during pregnancy, or a preventive effort that would involve exposing the woman to the hormone before pregnancy.

What’s next? Fejzo is applying for funding to test whether metformin, a drug that increases GDF15 levels and could thus “prime” the patient, could be taken prior to pregnancy and prevent or lower the risk of HG.

A newly formed company, Materna Biosciences, recruited Fejzo as its chief scientific advisor as it develops a GDF15-based drug for HG. Several such drugs are already in clinical trials for cachexia, a condition that causes severe weight loss in patients with cancer.

Fighting bias and looking for a cure
Fejzo is pleased by Time’s “Women of the Year” designation, but she mostly hopes to raise greater awareness about the condition — and find better treatments or a cure.

“There continues to be bias. I spoke to a doctor this week who has a patient hospitalized,” Fejzo said. “Besides him, the whole rest of the team dismissed her inability to eat as depression. As soon as they gave her steroids, her nausea and vomiting lifted, she ate, and immediately her mood improved.

“I hope the recognition from Time inspires more women to go into science because hyperemesis is not the only condition that’s under researched,” Fejzo said. “We just need more women scientists out there.”


相关栏目:『学人动向
凯文凯利:最新5大预言 2025-06-25 [41]
江小涓:尽全力保持经济回升向好势头,三驾马车能用尽用 2025-07-01 [76]
27楼的血色遗书:985夫妻用生命叩问的环保真相 2025-06-25 [211]
最简单的就是最好的:再读格雷厄姆 2025-06-25 [155]
朱镕基之子清华演讲:犀利点评当前中国问题(深度醒脑) 2025-06-21 [287]
胡志华:国际供应链智能化趋势对我国影响及应对建议 2025-06-16 [371]
扎克·迈耶斯:全球监管合作是技术与可持续发展的关键 2025-06-16 [362]
斯坦福教授大卫·拉伯雷:美国高等教育一直处于混乱的状态,但也正如此,才取得了成功。 2025-06-11 [503]
梁文道:我们需要怎样的政治共识? 2025-06-03 [906]
经济学的四次革命 2025-05-28 [890]
相关栏目更多文章
最新图文:
:天津工业大学“经纬英才”引进计划 :浙江财经大学国际青年学者论坛的邀请函 (10/31-11/1) :美国加大审查范围 北大多名美国留学生遭联邦调查局质询 :天安门广场喜迎“十一”花团锦簇的美丽景象 马亮:做院长就能够发更多论文?论文发表是不是一场“权力的游戏”? :印裔人才在美碾压华裔:我们可以从印度教育中学到什么? :北京452万人将从北京迁至雄安(附部分央企名单) :《2019全球肿瘤趋势报告》
更多最新图文
更多《即时通讯》>>
 
打印本文章
 
您的名字:
电子邮件:
留言内容:
注意: 留言内容不要超过4000字,否则会被截断。
未 审 核:  是
  
关于我们联系我们申请加入后台管理设为主页加入收藏
美国华裔教授专家网版权所有,谢绝拷贝。如欲选登或发表,请与美国华裔教授专家网联系。
Copyright © 2025 ScholarsUpdate.com. All Rights Reserved.